Login

ITW Olivier Sonneville (DRH CS GROUP) et Marion Langlois (Elles Bougent) par Thomas Hugues | Pierre LOPEZ, Ceo, CS Group SASX:PAR 00:10:00

Share On Facebook Share On Twitter

Pierre LOPEZ is in the postion of Ceo at CS Group

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
global protectionism and the Trump Administration|Alexey Solovyov,Founder & CEO,A.partners
00:10:00
Edge is Fueling the Future of Technology|Anjney Midha,Founder,KPCB Edge
00:10:00
Heikki Haasmaa on the Importance of Diverse Perspectives in Designing Future Smart Cities | Heikki Haasmaa, CEO, Sitowise Group Oyj.
00:10:00
Atento Capital is an early-stage investment firm focused on unlocking unsung potential|Will Gray,Co-founder & Managing Partner,Atento Capital
00:10:00
CEO Alain Moussy Expounds on the Complex Journey of Masitinib Development in Interview| Alain Moussy, CEO, AB Science SA.
00:10:00
Phunware Inc (NASDAQ) COO Randall highlights Phunware's feature on Meraki and George Lucas' support for Disney CEO Bob Iger in a proxy fight.|Mike Snavely is Chief Executive Officer & Director of Phunware
00:10:00
Thomas Hanly Discusses Singular Health’s Growth and Vision in Interactive Q&A with Investors | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
Navigating Market Disruption: Insights from Brixmor Property Group's CEO Jim Taylor|CEO ,Brixmor Property Group Inc
00:10:00
Analyzing the Attorney General's DACA Announcement: Legal Realities and Corporate Response | Roger McNamee, CO-Founder, Elevation Partners.
00:10:00
Insights from Aptos Biosciences CEO on Drug Development and Healthcare Systems at Blum Burton Conference | William Rice, CEO, Aptose Biosciences Inc .
00:10:00
Forging Ahead: Natixis' Ambitious Growth Strategy | Nicolas Namias, CEO, Natixis .
00:10:00
Franchise Brands PLC (LON:FRAN) shares rose today following CEO Stephen Hemsley's update on recruitment strategies during an interview with Proactive London.

© 2026 Nehu